Wyndham Wilson
Wyndham Wilson
National Cancer Institute
Verified email at
Cited by
Cited by
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh, MB Eisen, RE Davis, C Ma, IS Lossos, A Rosenwald, ...
Nature 403 (6769), 503-511, 2000
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald, G Wright, WC Chan, JM Connors, E Campo, RI Fisher, ...
New England Journal of Medicine 346 (25), 1937-1947, 2002
Stromal gene signatures in large-B-cell lymphomas
G Lenz, G Wright, SS Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, ...
New England Journal of Medicine 359 (22), 2313-2323, 2008
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
RE Davis, VN Ngo, G Lenz, P Tolar, RM Young, PB Romesser, ...
Nature 463 (7277), 88-92, 2010
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
JN Kochenderfer, ME Dudley, SA Feldman, WH Wilson, DE Spaner, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2709-2720, 2012
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave, G Wright, B Tan, A Rosenwald, RD Gascoyne, WC Chan, ...
New England Journal of Medicine 351 (21), 2159-2169, 2004
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
JN Kochenderfer, WH Wilson, JE Janik, ME Dudley, M Stetler-Stevenson, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4099-4102, 2010
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ...
The Journal of experimental medicine 194 (11), 1639-1648, 2001
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald, G Wright, K Leroy, X Yu, P Gaulard, RD Gascoyne, ...
Journal of Experimental Medicine 198 (6), 851-862, 2003
Genetics and pathogenesis of diffuse large B-cell lymphoma
R Schmitz, GW Wright, DW Huang, CA Johnson, JD Phelan, JQ Wang, ...
New England Journal of Medicine 378 (15), 1396-1407, 2018
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile
A Wiestner, A Rosenwald, TS Barry, G Wright, RE Davis, SE Henrickson, ...
Blood 101 (12), 4944-4951, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ...
Cancer cell 3 (2), 185-197, 2003
Molecular diagnosis of Burkitt's lymphoma
SS Dave, K Fu, GW Wright, LT Lam, P Kluin, EJ Boerma, TC Greiner, ...
New England Journal of Medicine 354 (23), 2431-2442, 2006
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
WH Wilson, RM Young, R Schmitz, Y Yang, S Pittaluga, G Wright, CJ Lih, ...
Nature medicine 21 (8), 922-926, 2015
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Y Herishanu, P Pérez-Galán, D Liu, A Biancotto, S Pittaluga, B Vire, ...
Blood, The Journal of the American Society of Hematology 117 (2), 563-574, 2011
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
R Schmitz, RM Young, M Ceribelli, S Jhavar, W Xiao, M Zhang, G Wright, ...
Nature 490 (7418), 116-120, 2012
Antineoplastic agents
BA Chabner, PC Amrein, BJ Druker, MD Michaelson, CS Mitsiades, ...
The pharmacological basis of therapeutics 9/e, 1315-1465, 2006
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour …
WH Wilson, OA O'Connor, MS Czuczman, AS LaCasce, JF Gerecitano, ...
The lancet oncology 11 (12), 1149-1159, 2010
Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling
K Fu, DD Weisenburger, TC Greiner, S Dave, G Wright, A Rosenwald, ...
Blood 106 (13), 4315-4321, 2005
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia
RJ Kreitman, WH Wilson, K Bergeron, M Raggio, M Stetler-Stevenson, ...
New England Journal of Medicine 345 (4), 241-247, 2001
The system can't perform the operation now. Try again later.
Articles 1–20